Efficacy and Safety of Lersivirine (UK-453,061) versus Efavirenz in Antiretroviral Treatment-Naïve HIV-1-Infected Patients
about
Non-nucleoside reverse transcriptase inhibitors: a review on pharmacokinetics, pharmacodynamics, safety and tolerabilityEfavirenz-Based Regimens in Antiretroviral-Naive HIV-Infected Patients: A Systematic Review and Meta-Analysis of Randomized Controlled TrialsA review of the virological efficacy of the 4 World Health Organization-recommended tenofovir-containing regimens for initial HIV therapy.Novel clinical trial designs for the development of new antiretroviral agentsAntiviral drug resistance and the need for development of new HIV-1 reverse transcriptase inhibitors.Investigational reverse transcriptase inhibitors for the treatment of HIV.Clinical use of vaginal or rectally applied microbicides in patients suffering from HIV/AIDS.Non-nucleoside reverse transcriptase inhibitor (NNRTI) cross-resistance: implications for preclinical evaluation of novel NNRTIs and clinical genotypic resistance testing.Effects of ketoconazole and valproic acid on the pharmacokinetics of the next generation NNRTI, lersivirine (UK-453,061), in healthy adult subjects.
P2860
Q24628212-CE9C32CC-25F8-4CED-812E-D1913AE05D82Q28081266-35D29EB0-BE17-4849-9AF2-520E8942B6D2Q35771321-423C43A2-0D19-4598-90F2-A340E2C9072EQ35931303-A8FA0CB3-2107-413B-B9F3-7D4D15C985EEQ36276790-68F615B0-0CD3-4170-A5E3-846055F3D1B4Q36306231-BA721B07-8D10-46E9-852F-94263FF0EE0AQ37255082-577A8447-D406-4875-9956-09C8971E9789Q42101552-C658967E-56D1-43D7-91FD-C6E1D2FE96C8Q42246959-3E083C67-A8DB-4164-9EA4-B2EEA207EED3
P2860
Efficacy and Safety of Lersivirine (UK-453,061) versus Efavirenz in Antiretroviral Treatment-Naïve HIV-1-Infected Patients
description
article
@en
im Oktober 2012 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована в жовтні 2012
@uk
name
Efficacy and Safety of Lersivi ...... -Naïve HIV-1-Infected Patients
@en
Efficacy and Safety of Lersivi ...... -Naïve HIV-1-Infected Patients
@nl
type
label
Efficacy and Safety of Lersivi ...... -Naïve HIV-1-Infected Patients
@en
Efficacy and Safety of Lersivi ...... -Naïve HIV-1-Infected Patients
@nl
prefLabel
Efficacy and Safety of Lersivi ...... -Naïve HIV-1-Infected Patients
@en
Efficacy and Safety of Lersivi ...... -Naïve HIV-1-Infected Patients
@nl
P2093
P50
P1476
Efficacy and Safety of Lersivi ...... -Naïve HIV-1-Infected Patients
@en
P2093
Anton Pozniak
Cunshan Wang
David. A. Cooper
Elizabeth Weil
Hernan Valdez
James Goodrich
Julie Mori
Margaret Tawadrous
Pietro Vernazza
Piotr Pulik
P356
10.1097/QAI.0B013E31827A2BA2
P407
P577
2012-10-01T00:00:00Z